ITC Partners With Amway To Develop Range Of Immunity Boosting Products

With sales of immunity building products seeing an uptick in demand after the Covid-19 outbreak, FMCG giant has partnered with direct selling company Amway India to launch a range of products in the segment, the first being a one-of-its-kind immunity offering in fruit beverages.

Priced at Rs 130, the new B Natural + range of fruit juices contain clinically proven immunity boosters and will be sold by Amway’s micro-entrepreneurs for a limited time period, before starts using its pan-India distribution network.

“At ITC, we are unique in the number of product formats that we have and each of these formats can actually be leveraged for a specific consumer benefit with the product and nutrition science that Amway has and our ability to do product development on those,” said Hemant Malik, Divisional Chief Executive − Foods Division, He said this is the first glimpse of an immunity product and several others will be launched in the coming months.

Reports say demand for immunity-building products has gone up four times post-Covid-19. While FMCG such as Dabur have posted overall losses during the fourth quarter, immunity products such as chyawanprash and honey have seen over an 80 per cent surge in demand.

Experts say even juices are benefitting from more in-home consumption. “Apart from regular benefits of health and Ayurveda focus, juices could get the much-needed fillip to growth. We note that juices performance could improve benefiting from greater in-home consumption versus other beverage categories like carbonated soft drinks,” said ICICI Securities in a note.

According to Malik, ITC and Amway were already in talks for a strategic collaboration long before the signs of Covid19 emerged in India and the outbreak fast-tracked the partnership.

Amway India CEO Anshu Budhraja said it is piloting and testing ground and also deploying resources and science-based research to strengthen the partnership further.

“As we inch towards the food segment, we are confident of creating immense value for people through this partnership and further solidify our leadership in the health and immunity domain,” said Budhraja.

RECENT NEWS

HSBC Swings The Axe At UK Wealth In An AI Push

HSBC is preparing deep job cuts across its UK wealth management arm. It plans to cut about half of its management and sp... Read more

Kraken's Owner Buys A Bank: The Lines Are Blurring

Payward, the parent company of the crypto exchange Kraken, has agreed to buy a European bank. It would be the first digi... Read more

Revoluts Australian Banking Licence Game Changer

Revolut has spent much of its life insisting that it is more than a bank. In Australia, it has now decided that becoming... Read more

The AI Bank Is Coming, But Who Controls The Risk?

Artificial intelligence is no longer something banks discuss as a distant possibility. It is already working behind the ... Read more

ClearBank UK Profit Leads To European Growth

ClearBank has spent much of the past decade building the technology and regulatory infrastructure needed to challenge so... Read more

Bank Of London Continues To Rebuild

ClearBank’s progress shows that modern clearing and banking infrastructure can become a sizeable and profitable busine... Read more